Journal:
:Brazilian Archives of Biology and Technology2021
HIGHLIGHTS Boceprevir is a potential therapeutic that targets the main protease of SARS-CoV-2. Mutations change inhibitory binding pattern in catalytic domain protease. SARS-CoV-2 cause decrease boceprevir affinity.